Literature DB >> 35669012

Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas.

Christopher M Rota1, Alexander T Brown2, Emily Addleson1, Clara Ives2, Ella Trumper2, Kristine Pelton3, Wei Pin Teh1, Matthew J Schniederjan4, Robert Craig Castellino5, Sara Buhrlage1, Douglas A Lauffenburger2, Keith L Ligon3, Linda G Griffith2, Rosalind A Segal1.   

Abstract

Background: Pediatric gliomas comprise a diverse set of brain tumor entities that have substantial long-term ramifications for patient survival and quality of life. However, the study of these tumors is currently limited due to a lack of authentic models. Additionally, many aspects of pediatric brain tumor biology, such as tumor cell invasiveness, have been difficult to study with currently available tools. To address these issues, we developed a synthetic extracellular matrix (sECM)-based culture system to grow and study primary pediatric brain tumor cells.
Methods: We developed a brain-like sECM material as a supportive scaffold for the culture of primary, patient-derived pediatric glioma cells and established patient-derived cell lines. Primary juvenile brainstem-derived murine astrocytes were used as a feeder layer to support the growth of primary human tumor cells.
Results: We found that our culture system facilitated the proliferation of various primary pediatric brain tumors, including low-grade gliomas, and enabled ex vivo testing of investigational therapeutics. Additionally, we found that tuning this sECM material allowed us to assess high-grade pediatric glioma cell invasion and evaluate therapeutic interventions targeting invasive behavior.
Conclusion: Our sECM culture platform provides a multipurpose tool for pediatric brain tumor researchers that enables both a wide breadth of biological assays and the cultivation of diverse tumor types. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology 2022.

Entities:  

Keywords:  diffuse midline glioma (DMG); juvenile pilocytic astrocytoma (JPA); pediatric low-grade glioma; synthetic extracellular matrix; tumor cell invasion

Year:  2022        PMID: 35669012      PMCID: PMC9159660          DOI: 10.1093/noajnl/vdac049

Source DB:  PubMed          Journal:  Neurooncol Adv        ISSN: 2632-2498


  26 in total

1.  Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

Authors:  Barbara S Paugh; Chunxu Qu; Chris Jones; Zhaoli Liu; Martyna Adamowicz-Brice; Junyuan Zhang; Dorine A Bax; Beth Coyle; Jennifer Barrow; Darren Hargrave; James Lowe; Amar Gajjar; Wei Zhao; Alberto Broniscer; David W Ellison; Richard G Grundy; Suzanne J Baker
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

2.  A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.

Authors:  Yu Sun; John A Alberta; Catherine Pilarz; David Calligaris; Emily J Chadwick; Shakti H Ramkissoon; Lori A Ramkissoon; Veronica Matia Garcia; Emanuele Mazzola; Liliana Goumnerova; Michael Kane; Zhan Yao; Mark W Kieran; Keith L Ligon; William C Hahn; Levi A Garraway; Neal Rosen; Nathanael S Gray; Nathalie Y Agar; Sara J Buhrlage; Rosalind A Segal; Charles D Stiles
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

3.  Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2.

Authors:  J Patterson; J A Hubbell
Journal:  Biomaterials       Date:  2010-07-27       Impact factor: 12.479

4.  Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.

Authors:  Aparna Kaul; Yi-Hsien Chen; Ryan J Emnett; Sonika Dahiya; David H Gutmann
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

Review 5.  Histologic classification of gliomas.

Authors:  Arie Perry; Pieter Wesseling
Journal:  Handb Clin Neurol       Date:  2016

Review 6.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

7.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

Review 8.  3D biomaterial models of human brain disease.

Authors:  Janko Kajtez; Fredrik Nilsson; Alessandro Fiorenzano; Malin Parmar; Jenny Emnéus
Journal:  Neurochem Int       Date:  2021-04-20       Impact factor: 3.921

Review 9.  Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments.

Authors:  Ricardo Gómez-Oliva; Samuel Domínguez-García; Livia Carrascal; Jessica Abalos-Martínez; Ricardo Pardillo-Díaz; Cristina Verástegui; Carmen Castro; Pedro Nunez-Abades; Noelia Geribaldi-Doldán
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

10.  Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model.

Authors:  R Chase Cornelison; Caroline E Brennan; Kathryn M Kingsmore; Jennifer M Munson
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.